BridgeMD
New treatment option for Thromboembolic Venous Disease
Official title Prospective Cohort Study on the Determinants of Venous THromboembolic Recurrence
ClinicalTrials.gov ID: NCT04297085
What this study is testing
What is Biologic sample?
Biologic sample is an investigational medicine, being studied as a potential treatment for thromboembolic venous disease.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The main objective of the BREIZH-Cohorte study is to determine the incidence of recurrent short, medium and long-term thromboembolic venous disease as well as risk factors for recurrence in two specific populations: patients under 50 years of age, men and women (5 year recurrence), as well as cancer patients (all ages) (1 year recurrence).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Subject aged 18 or over, or a minor with the consent of the parents and the minor, presenting with a thromboembolic venous disease
- 50 and under or any age if active cancer
- Affiliated to social security
- Accepting to participate in the study.
You likely can't join if
- Inability to communicate (comprehension disorder).
- Refusal to participate.
The study team makes the final eligibility decision.
Where it's taking place
- Brest, France
- Morlaix, France
- Quimper, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brest, France; Morlaix, France; Quimper, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.